Zoledronic acid and Plendil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zoledronic acid (zoledronic acid) and Plendil (felodipine). Common drug interactions include juvenile idiopathic arthritis among females and carotid artery stenosis among males.

The phase IV clinical study analyzes what interactions people have when they take Zoledronic acid and Plendil. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Zoledronic acid?

Zoledronic acid has active ingredients of zoledronic acid. eHealthMe is studying from 28,485 Zoledronic acid users. Check the latest studies of Zoledronic acid.

What is Plendil?

Plendil has active ingredients of felodipine. It is often used in high blood pressure. eHealthMe is studying from 4,990 Plendil users. Check the latest studies of Plendil.

On Jul, 10, 2026

12 people who take Zoledronic acid and Plendil together, and have interactions are studied.

Zoledronic acid and Plendil drug interactions.

What are the common drug interactions of Zoledronic Acid and Plendil, by gender? *:

female:

Juvenile idiopathic arthritis (a subset of arthritis seen in childhood)
Peripheral swelling
Swelling
Ageusia (loss of taste functions of the tongue)
Vision blurred

male:

Carotid artery stenosis (narrowing of carotid artery)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Lacunar infarction (a type of stroke)
Sinus bradycardia (an unusually slow heartbeat due to heart disease)
Encephalopathy (functioning of the brain is affected by some agent or condition)
International normalised ratio decreased
Metastases to bone (cancer spreads to bone)
Metastases to spine (cancer spreads to spine)
Prostate cancer
Carotid artery dissection

What are the common drug interactions of Zoledronic Acid and Plendil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Juvenile idiopathic arthritis (a subset of arthritis seen in childhood)
Peripheral swelling
Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
Lacunar infarction (a type of stroke)
Metastases to bone (cancer spreads to bone)
Metastases to spine (cancer spreads to spine)
Prostate cancer
Sinus bradycardia (an unusually slow heartbeat due to heart disease)
Vision blurred
Swelling

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 6 people, 50.00%
Prostate Cancer Metastatic: 2 people, 16.67%
Nausea (feeling of having an urge to vomit): 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
Joint Pain: 1 person, 8.33%
Insomnia (sleeplessness): 1 person, 8.33%
Indigestion: 1 person, 8.33%
Eye Disorder: 1 person, 8.33%
Constipation: 1 person, 8.33%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Zoledronic acid and Plendil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously